RivastigmineAnti-Alzheimers (CNS Preparations) Indication: Mild to moderate dementia caused by Alzheimer’s or Parkinson’s disease. Dosage & Administration: Initially, 1.5 mg Capsule twice a day. Preparation: Each box contains 20 Capsules in blister pack.